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In acute myocardial infarction, variables such as advanced
age, anterior myocardial infarction, extent of clectrocardio-
graphic (ECG) changes, evidence of acute left heart failure
and history of previous infarction or diabetes mellitus all
identify patients at higher risk of death (1,2). However, for
early clinical decision making it would be much more impor-
tant to be able to identify within a particular risk group the
individual patient with a relatively good or an exceptionally
unfavorable prognosis. Ideally, such early assessment
should be simple, quick, noninvasive and easy to use in all
patients with evolving myocardial infarction .
Findings from a study of EC6 prediction of coronary
artery patency after thrombolytic therapy suggested that the
amount of early resolution of ST segment elevation might be
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Results. For complete, partial and no ST segment resolution
3 h after the start of streptokinase or placebo infusion, enzyme
release was 1 .2, 1 .8 and 2.1 IU/nd x h; number of Q waves 1 .7,
2.5 and 3 .0; and ejection fraction 60%, 53% and 49%, respvcs
tively (all adjusted p = 0.0000). Mortality rate at 21 days was
2.2%, 3.4% and VIA% respeedvely. No ST segment resolution
was the most powerful independent predictor of early mortality
(p = 0.001). Survival rate curves at 6-year follow-up showed
significant mortality differences with increasirig divergence (p =
COOK03 anterior infarction; p = 0 .00 inferior infarction) . In
subgroups with an overall higher risk of dying, morWity was
st®roangly determined by the extent of early ST segment resolution .
Conclusions. The extent of ST segment elevation resolution
conveys useful early information about outcome In an individual
patient after acute myocardial infarction .
(J Am Cell Cardio 1"4;24.384-91)
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a useful prognosticator (3) . In contrast to other ST segment
markers with a higher sensitivity for coronary perfusion,
resolution of ST segment elevation z70% at 3 h after the
start of thrombolytic therapy was a major predictor of
favorable outcome (3) . However, it appeared clinically
meaningful not only to distinguish patients with a favorable
outcome (ST segment resolution L-707b) but also those who
couldd be expected to have a poor prognosis . According to
a study by Saran et al . (4), <30% ST segment resolution
appeared to be a useful cutoff point for predicting a partic-
ularly unfavorable outcome. Accordingly, we performed a
prospective study in 77 patients with acute myocardi-0
infarction and thrombolysis within 6 h after symptoin
ST segment resolution, as measured by the two cutoff points
(ST segment resolution a-7017c and <30%), at 3 h after the
start of thrombolysis significantly predicted enzy ,7natic in-
farct size and angiographic left ventricular function (5) .
We therefore proposed to verify the prognostic power of
these different amounts of ST segment resolution ~, agog data
from the Intravenous Streptokinase in Acute ocardial
Infarction (ISAM) (6) study data base, which provides a
large, well characterized patient group for whom m.ultivari-
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ate analyses can be performed to identify independent de-
terminants of mortality .
Methods
Study population . The ISAM study was a double-blind,
placebo-controlled German-Swiss-Canadian multicenter
trial in which streptokinase therapy revealed significant
limitation in enzymatic infarct size, better global and re-
gional ejection fraction I month after infarction and a trend
toward reducedd mortality (6,7) . Between March 1982 and
March 1985, 1,741 patients <76 years of age were randomly
allocated to receive either 1 .5 MU of streptokinase or
placebo infusion . Immediately after randomization, strep-
tokinase or placebo infusion was started, combined with a
bolus injection of 5,0M IU of heparin and 0 .5 g of acetylsa-
licylic acid and followed by heparin infusion continued for 72
to 96 h with overlapping phenprocoumon treatment for at
least 3 weeks . A 12-lead ECG was recorded before and 3 h
after randomization . Evolving myocardial infarction was
diagnosed when typical symptoms and ST segment elevation
of at least 0.1 mV in two limb leads or 0.2 mV in two
contiguous chest leads were present .
Of the 1,741 randomized patients, 225 had to be excluded
from the present analysis : 20 patients died within 3 h after
randomization or had cardiac arrest and died shortly there-
after ; 120 patients had bundle branch block or ventricular
rhythm (mostly pacing), 30 of whom died within 21 days . Of
the remaining 85 patients, 48 had no significant ST segment
elevation in their prerandomization ECG (sum of ST seg-
ment elevation <2 mm), and 37 patients (2%) had no
available ECG 3 h later . Of these 85 patients, 5 died within 21
days. Therefore . 1,516 study patients comprised all patients
eligible for thrombolytic therapy : :56 h of onset of myocar-
dial infarction symptoms, who had no bundle branch block
and survived the 1st 3 h after hospital admission .
Electrocardiographic analysis . The sum of ST segment
elevation was measured 20 ms after the end of the QRS
complex from leads 1, aVL and V1
to V6
for anterior and
leads 11, 111, aVF and V5 to
V6
for inferior myocardial
infarction . ST segment depression was not measured . The
development of new Q waves (Minnesota code criteria) was
calculated from the difference from the number of leads with
Q waves in the prerandomization ECG and that 3 weeks later
M. All measurements were performed at a core laboratory
that had no knowledge of treatment assignment or outcome .
The first ECG was recorded before randomization, on aver-
age 72 min after admission (prerandomization or baseline
ECG), and the second ECG 3 h after the start of streptoki-
nase or placebo infusion, which was initiated immediately
after randomization .
Enzyme analysis. Creatine kinase isoenzymes, MB frac-
tion (CK-MB), serum activity was measured in 2-h intervals .
The enzyme infarct size was calculated from the area under
the curve .
The time to peak CK-MB activity was measured
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by the interval between the start of treatment and maximal
serum CK-MB activity (6),
Quantitative angiographic analysis . Analysis of global
ejection fraction and regional dyssynergic area of the left
ventricle related to the infarct-related artery was performed
in 818 patients I month after infarction (6) . Patients who had
angiography were younger than those who did not (55 vs . 62
years); 45% who had angiography had anterior infarction ;
50% had streptokinase therapy; and 49% had complete, 31%
partial and 20% no ST segment resolution .
Follow-up. During the 1st 7 months, all critical events,
including reinfarction, were reviewed by an independent
critical event committee . Follow-up >7 months concerned
total mortality only, evaluated by inquiries based on the
government's registry . At a cutoff date of August 31, 1986,
no vital status could be obtained for six patients . After
August 1986 the remaining 132 Canadian patients were no
longer followed up. For 79 patients the 2-year follow-up was
not completed at that time . At the final cutoff date of August
31, 1991, only 17 of the German and Swiss patients were lost
10 follow-up,
Prognostic ST segment resolution groups. During clinical
routine use of the extent of ST elevation resolution as a
prognostic marker it had become obvious that for slight ST
elevation, measures of percent resolution were imprecise
and impracticable . Because these patients usually have a
good prognosis, for purposes of this analysis they were
included in the group of patients with complete ST segment
resolution: 1) Complete resolution was defined as resolution
of the initial sum of ST segment elevation ?70% 3 h after
randomization or only slight ST segment elevation (sum of
ST segment elevation at baseline 0 .2 to 0 .4 mV for anterior
ischemia and 0 .2 mV for inferior ischemia and at least no
increase 3 h later) ; 2) partial resolution as ST segment
resolution <70% to 30% ; and 3) no resolution as ST segment
resolution <30% to >0% .
Statistical analysis. Univariate analyses of differences
between ST segment resolution groups were performed
using one-way analysis of variance (ANOVA) (F tests) for
continuous outcome variables and Pearson chi square tests
with Yates correction for discrete outcome variables (mor-
tality) .
For all multivariate analyses, a combination of 10 dichot-
omous or dichotomized baseline factors, in addition to ST
resolution, were used as covai0s: 1) age a65 years, 2)
male gender, 3) anterior myocardial infarction, 4) evidence
of acute left heart failure (pulmonary rates or pulmonary
conges tion , or both. on chest X-ray film), 5) history of
congestive heart failure, 6) previous myocardial infarction,
7) angina pectoris >4 weeks before infarction, 8) diabetes
mellitus, 9) treatment with streptokinase, and 10) baseline
sum of ST segment elevation > 1 .2 mV for anterior infarction
and >0.6 mV for inferior myocardial infarction, respectively
(large sum of ST segment elevation) .
A fixed-effect multiway ANOVA was performed for three
continuous outcome variables using the 10 baseline factors
Segment Elevation Resolution 3 h After Allocation to Streptokinase or Placebo Infusion
Data presented are mean value_ SD or number (%) of patients.
and the three ST segment resolution groups as additional
factors, with no interactions admitted . From these analyses
we report the adjusted mean values for the three ST segment
resolution groups and the p values for the corresponding F
test. For overall mortality at 21 days, 2- and 5-year logistic
regressions were performed using the same 10 baseline
factors and the three ST segment resolution groups as an
additional factor with no interactions admitted . The adjusted
odds ratios, confidence intervals and p values are reported .
In addition, analyses with two ST segment resolution groups
(cutoff points 30% or 70%, respectively) were repeated . The
raw and adjusted odds ratios for all significant factors with a
cutoff point at 30% are also reported . Survival curves for the
three ST segment resolution groups were then estimated
according to Kaplan-Meier; comparisons were made using
the log-rank statistic . Calculations were made using the
procedures ONE WAY, ANOVA and logistic regression of
SPSSPC, Version 4.0, and the procedures PLR and PIL of
the mainframe version of BMDP.
Results
Study pu Ls (Table 1) . Of the 1,516 ISAM study pa-
tients with significant ST segment elevation and initiation of
study drug infilsion within 6 h after onset of acute myocar-
dial infarction symptoms, the ECG recorded 3 h after the
start of streptokinase or placebo infusion revealed in 45% of
patients complete ('70%), in 31% partial (<70% to 30%) and
in 24% no resolution (<30%
to >0%) of their initial ST
elevation on the prerandomization ECG. The group with
complete resolution included 127 patients with only slight ST
segment elevation, as defined earlier (50 with anterior, 77
with inferior ischemia ; only I of these 127 patients died
within 21 days) .
Patients with no ST segment resolution were slightly
older, and the proportion of patients with diabetes was
nearly twice that in the other groups. Infarct location was
unevenly distributed . In the group with complete ST seg-
ment resolution, about two-thirds of patients had an inferior
infarction, and one-third had an anterior infarction ; in the
no-resolution group, this was reversed . The time intervals
from treatment start to maximal serum CK-MB activity were
significantly different among the three groups (11 .9 ± 5, 14 .2
6 and 15.8 ± 6 h, respectively, p = 0.1111) .
Infarct size, left ventricular function and 7-month reinfarc-
tion (Tables 2 and 3). The adjusted, actual infarct size, as
measured from the areas under the CK®MB serum activity
curves and the number of Q waves as well as ejection
fraction I month after infarction were significantly better
with complete than with partial, and better with partial than
with no, ST segment resolution. As shown in Table 3, the
outcome with either infarct location was similarly beneficial
with complete ST segment resolution, whereas the extent of
the increasingly worse outcome from complete (to partial
and) to no ST segment resolution was greater in anterior
myocardial infarction . New Q waves and angiographic in-
farct size were more than twofold with no, compared with
complete, ST segment resolution . However, in patients with
an inferior infarct location, the reinfarction rate was signifi-
cantly higher with complete ST segment resolution .
Table 2
. Infarct Size and Ejection Fraction in the Three Groups of ST Segment Resolution for All Patients After Adjustment for
Differences in Baseline Characteristics and Percent of Reinfarction at 7 Months
Data presented are mean value ± SD or number (%) of patients (pts)
. AUC = area under the enzyme serum time-activity curve; CK-MB = creatine kinase,
MB fraction .
Complete Resolution
(n = 679145%1)
Partial Resolution
(n = 475 [31%1)
No Resolution
(n = 362124%]) p Value
A8e (yr) 57.7 ¢ 10.2 57 .9 ± 9 .9 59 .3 ± 10.0 0.04
Time from symptom onset to treatment (min) 181 ± 79 188 ± 83 1 _ 90 NS
Male Wider 555(82) 3%(83) 287(79) NS
Anterior infarction 22804) 276(58) 217(60) 0.0000
Inferior infarction 451(66) 199(42) 14500)
Previous infarction 75(11) 44(9) 3901) NS
Diabetes mellitus 60(9) 5401) 6307) 0 .
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T 1. Clinical Characteristics of 1,516 ]SAM Study Patients With Acute Myocardial Infarction <6 h in Duration According to ST
Complete Resolution
(n = 679 [45%1)
Partial Resolution
(n = 475 [31%))
No Resolution
(n = 362 [24%)) p Value
CK-MB AUC (lUlml x h) 1 .2 ± 1 .1
1 .8 ± 1 .2 2 .1 * 1 .3 0.0000
New Q waves
1 .7 ± 1 .4
2.5 ± 1 .6 3 .0 ± 1 .6 9 .0000
Ejection fraction (%a)
60 ± 13 53 ± 14 49 ± 14 6.0000
No.(%) of pts with reinfarct on
47(6.9) 20(4.2) 15(4 .1) 0.06
1ACC Vol, 24, No. 2
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Table 3 . Infarct Size, Left Ventricular Function and 7-Month Reinfarction Rate in Patients With Anterior or Inferior Myocardial
Infarction According to Complete or No ST Segment Resolution
Short. and long-term mortality rates (Table 4, Fig. 1) .
Overall mortality rates at 21 days and 2 and 5 years and
adjusted relative risks of dying between complete and partial
and complete and no ST segment resolution, respectively,
were highly significantly different . The actuarial curves for
survival with 6-year follow-up in Figure 1 for anterior and
inferior infarction show highly significantly mortality differ-
ences among the three groups, with increasing divergence,
particularly for partial ST segment resolution in anterior
infarction . With complete ST segment resolution, long-term
mortality was similarly low with either infarct location .
Prognostic impact of the extent of ST segment resolution in
risk subsets (Table 5), The 2-year mortality rates by clinical
variables, identified to be independent predictors of survival,
are subdivided by the three groups of ST segment resolution
in Table 5. There were relatively minor differences in all
patients with an initially small or large extent of ST segment
elevation (2-year mortality rate 11 .3% and 14.4%, respec-
tively), but those with complete ST segment resolution 3 h
later had less than half the mortality risk (6 .5% and 9.9%,
respectively) than those with no ST segment resolution
(19.0% and 22 .8%, respectively). Thus, the initial extent of
ST segment elevation is less relevant than the amount of
SCHWDER ET AL .
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*All patients with anterior or inferior infarction (F test p values) . tOn the baseline (Prerandoinization) electrocardiogram
. Data presented are mean value
SD or number (%) of patients (pis) . DA = dyssynergic area of the left ventricle ; other abbreviations as in Table 2 .'
resolution afterward. Accordingly, for each risk subset mor-
tality varied considerably in relation to the awount of early
ST segment resolution . For example, a patient with reinfare-
tion and no ST segment resolution had a mortality risk rate
of 46016, whereas it was only 13% with complete ST segment
resolution .
Thrombolyfic therapy (Fig. 2). The power to predict
infarct size and mortality from the amount of ST segment
resolution was the same regardless of whether patients had
been allocated to streptokinase or placebo infusion . In the
groups with complete, partial or no ST segment resolution,
CK-MB serum activity curves in streptokinase group pa-
tients were, respectively, 1 . 3, 1 .8 and 2 .0 IIJ/H x h, and in
placebo group patients 1 .2, 1 .9 and 2.1 Mini x h ; left
ventricular ejection fraction was 60%, 55% and 50% versus
60%, 52% and 48%, respectively ; and 2-year mortality risk
rate was 8.9%, 13 .4% and 19 .7% versus 6 .9%, 13.9% and
21 .4%, respectively .
ThL percent of patients with complete, partial or no ST
segment elevation was significantly different between strep-
tokinase-treated and placebo-treated patients (p = 0-M).
The percent of patients with complete ST segment resolution
was greater in the streptokinase group compared with the
Table 4. Deaths and Odds Ratios (relative risks) for Death After Adjustment for Differences in
Baseline Characteristics in the Three Groups of ST Segment Resolution for All Patients at 21 Days
and 2 and 5 Years
1	- 1.8 (1 .3-2 .6)
*p values for combined analysis
. RR = relative risks (odds ratio) followed in parenthesis by 95% confidence
intervals (CI) for complete versus partial (uppei rows) and complete versus no (lower rows) ST segment resolution
.
Anterior MI (n = 721) Inferior Ml (n = 795)
Complete Resolution
(n = 228 [327o])"
No Resolution
(n = 217130'Yol)* p Value*
Complete Resolution
(n = 451 [57%1)*
No Resolution
(a = 145 JIM])" a Value*
Sum of ST segment elevationt 1 .7 t 1 .1 1 .4 ± 0.8 0.002 0.8 ± 0.05 0.8 ± 0.05 NS
CK-MB AUC (lU/ml x h) 1 .2 t 1 .3 2 .2 t 1 .4 lm 2.0 ± 1 .2 O.M
New Q waves 1 .7 1 .7 3 .5 ± 1 .8 0 N 0 1 .7 t 1,2 2.4 ± LI III
NwHon fraction 61 15 47±15 0.0000 60 ± 12 51 11 0.0000
Regional DA (square units) 17 19 39 ft: 23 0.M 17 t 15 26 14 0.0000
No. (%) of pts with reinfarction 17(7.5) 12(5 .5) NS 30(6 .7) 3 (2 .1) 0.05
Complete Resolution Partial Resolution
(n = 679 [45%]) (n = 475 [31%])
No Resolution
(n = 362 [24%]) p value
No. (%) of deaths at 21 days 15 (2 .2) 16(3 .4)
31 (8 .6) 0 .00=00
RR (95% Cl) 1 1 .3 (Ok-2-8) __J
0 .0005*
1 - - - 13 (1 .7-6 .6) J
No (%) of deaths at 2 yr 52 (8& 61031
71 U0.8) 0 .0000
RR (95% CI) 1 1 .7 (1 .1-2.6)
0 .0003*
No. (%) of deaths at 5 yr
1 2 .4 (1 .6-3 .6)
0.0000101 (24 .0) 10201 .0)100(16 .4)
-
RR (95% Cl) L_ 1
.4 (1 .0-2 .0) 1 0.004*
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Figure 1 . Kaplan-Meier survival curves for patients with acute
myocardial infarction (MI) <6 h in duration with complete, partial or
no ST segment resolution at 3 h after randomization to streptokinase
or placebo infusion. The numberofpa at risk at each time point
arc noted above the x axes for complete, partial and no ST segment
resolution .
placebo group, and there were fewer patients with persistent
ST segment elevation with thrombolytic therapy .
Mulitiv to analysis with one ST t resolution cutoff
point (Table 6) . With a cutoff point at 30%, multivariate
logistic regression analysis revealed four covariates that
were independent predictors of 21-day mortality . The ad-
justed odds ratios ranged from 2 .9 for <30% ST segment
resolution to 1 .8% for large ST segment elevation on the
baseline ECG. For long-term mortality at 2 years advanced
age became the best single predictor, whereas previous
myocardial infarction, evidence of acute left heart failure
and a history of diabetes were added as independent risk
factors. ST segment elevation resolution <30% remained an
independent significant predictor of death, with an odds ratio
of 1 .9 at 2 years. For an ST segment resolution cutoff point
at 70% (i.e ., complete ST segment resolution group), the
adjusted odds ratio for 21-day mortality was 2 .1 (95%
confidence interval [CI] 1 .2 to 4.0) and for 2-year mortality
2.0 (95% CI 1 .4 to 2.8) .
JACC Vol . 24, No . 2
Discussion
In patients with acute myocardial infarction, several
variables associated with an increased mortality risk can be
evaluated within minutes of the patient's arrival at the
hospital (1,2) . The present analysis confirmed older age,
previous infarction, clinical evidence of acute left heart
failure, diabetes, anterior myocardial infarction and greater
extent of initial epicardial injury to be independent prognos-
ticators of increased mortality . However, for early clinical
decision making the presence or absence of these risk factors
appeared to be of little actual relevance . None of them alone
would probably change clinical routine management deci-
sions in individual patients .
In contrast, the extent of early resolution of ST segment
elevation in patients with evolving myocardial infarction
<6 h in duration strongly discriminates individual patients
with a favorable outcome from those with a poor one. The
most important result from the present analysis is the finding
that for all clinical variables the risk modification due to the
amount of early ST segment resolution is striking (Table 5),
Except for diabetes, high risk patients with complete ST
segment resolution always have a better long-term outcome
than patients without that particular risk but with no ST
segment resolution.
We defined three groups according to complete (~70%),
partial (<70% to 30%) and no (<30% to >0%) ST segment
resolution to differentiate patients with a very good progno-
sis from those with a particularly poor one, leaving an
intermediate group. Because patients presenting with only
slight ST segment elevation at hospital admission and at least
no increase in ST segment elevation 3 h later comprise a
good risk group in itself, they were included in the group
with complete ST segment resolution . The predictive power
of these three groups in terms of infarct size, left ventricular
function and survival is surprisingly strong regardless of
whether patients have had streptokinase treatment . A ben-
eficial effect of thrombolytic therapy is related to a larger
proportion of patients with complete ST segment resolution
and less with persistent ST segment elevation (Fig . 2) .
Using multivariate logistic regression with ST segment
resolution dichotomized at a cutoff point of 30%, we identi-
fied seven factors that were independently associated with
increased mortality. The most powerful predictor of 21-day
mortality was the absence of a reduction ?30% in ST
segment elevation (i .e., no ST segment resolution). As
expected, during long-term follow-up, age became the factor
of overriding prognostic importance . However, lack of early
ST segment resolution remained a good discriminator after
age and previous myocardial infarction at 2-year follow-up
(Table 6). Changing the ST segment resolution cutoff point
from 30% to 70%® for 21-day mortality resulted in a smaller
odds ratio, indicating that for short-term mortality the partial
ST segment resolution group is closer to the complete ST
segment resolution group than to the no ST segment resolu-
tion group. However, at 2-year follow-up both complete and
60
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Table S. Two-Year
Mortality by Clinical Variables in the Three Groups
of ST Segment Resolution
"On the baseline (prerandomization ) electrocardiogram- small :50,6 mV in inferior and !51 .2 mV in anterior myocardial infarction (MI) ; large >0.6 mV in
inferior and >1 .2 mV in anterior myocardial i nfarction . tp = 0.00 0,
	
= 0.0002 for mortality differences of the clinical variables in all patients (Pts) (overall) .
no ST segment resolution were identified as independent
predictors of mortality with almost identical power .
Mechanisms of ST segment elevation resolution. There is
no evidence to suggest that patients with no ST segment
resolution might have had a larger infarct . On the contrary,
the extent of the initial epicardial injury, as measured by the
sum of ST segment elevation, was significantly smaller in
patients with an anterior myocardial infarction with no ST
resolution (Table 3), reflecting potentially even smaller in-
farcts (7) .
There is still controversy about the usefulness of early ST
segment changes as a marker of reperfusion (3-5,8-10) .
Hgare 2. Percent of patients with complete, partial or no ST
segment resolution at 3 h after randomization for all patients and
those allocated to receive streptokinase or placebo .
401
20
041_% 2
45%
Im
54%
EM
3
EMU
36%
All Streptokinase Placebo
E]
complete @ partial N no
ST 00% <70-300/6 -300/6
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However, there is consensus that ST segment elevation
resolution in the range ?709b' is associated with infarct-
related artery patency from drug-induced or spontaneous
reperfusion (3,5,8-10) . Complete ST segment resolution
a70% was present in 54% of our thrombolysis group patients
and in 36% of our placebo group patients as well (Fig . 2),
which may reflect spontaneous reperfusion during anticoag-
ulation (11,12) .
Absence of at least 30% ST segment resolution at 3 h after
thrombolysis will be highly specific (albeit less sensitive) for
lack of reperfusion (3-5,8,9) . Although most patients with
partial ST segment resolution achieve reperfusion (3-5,8,9),
they develop larger infarcts (5) . This refers particularly to
patients with initially complete occlusion of the proximal left
anterior descending coronary artery without good collateral
vessels, who often show transient additional ST segment
elevation at the time of reperfusion (13,14) .
Continuous ST segment monitoring and serial coronary
angiography have shown that spontaneous intermittent re-
canalization and reocclusion with corresponding ST segment
shifts are frequent during the early phase of myocardial
infarction (15,16) . However, the strong predictive power of
ST segment resolution measured at a fixed interval of 3 h
after the start of streptokinase or placebo infusion suggests
no major interference with ST segment fluctuations. In the
preceding study (5), a 12-lead ECG was
recorded every
5 min. Of those patients with complete ST segment resolu-
tion 3 h after initiation of thrombolysis, 26% had ST segment
fluctuations after an initial resolution
. They had a favorable
outcome, similar to those patients without early ST segment
fluctuations (5) .
Mortality (%) by ST Segment Resolution at 3 h
No. of Pis Overall Mortality (%)
Complete Partial None
p Value
All patients 1
.431 12.9
8 .1 13 .7 20.8 0
.0000
Sum of ST segment elevation'-
Small 715 11 .3
6 .5 12 .5 19.0
0 .0001
Large 716 14.4 9,9
14 .6 22.8
0 .0009
Age
<65 yr I 'M 8.8 5.7
8.7 15 .3 0 .0002
165 yr 427
215, 14 .1
26 .8
30.8
0 .001
Infarct location
Inferior 748 9.6 6.8
11 .2 16.4 0 .003
Anterior 683 16 .44 10.6 15 .4
23 .6 0 .001
Acute heart failure
No
1,149
10.4
7 .1 12,1
15 .3 0 .001
Yes 282 22.74
13 .2 20 .7 35 .1 0 .001
Previous Ml
No 1,283 11 .4 7 .5
12 .1 17 .7 0 .0000
Yes 148 25.7t 12 .9
29 .3 45 .9 0 .0008
Diabetes
No 1,261 I L 2 6 .8 12 .2 18 .9 0 .0000
Yes 170 25.34 21
.4
24 .5 29.5 NS
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Multivariate Analysis for Prediction of 21-Day and 2-Year Mortality Based on ST
Segmcnt Resolution <30% at 3 h, 10 Other Baseline Variables and, for Comparison, Unadjusted
(raw) Odds Ratios
Odds Ratio Odds Ratio 95% p
(raw) (adjusted) C1'" Value*
*For adjusted odds ratios . tOn the baseline electrocardiogram >1 .2 mV in anterior and >0 .6 mV in inferior
myocardial i
nfarction . CI = confidence intervals.
Clinical IM . The extent of early ST segment
elevation resolution as a prognostic indicator has been
addressed in three previous studies . Richardson et al. (17)
found that an abrupt reduction in ST segment elevation
within the 1st 3 h after the start of thrombolysis was strongly
predictive for an open infarct-related coronary ante : y ; how-
ever, sensitivity was lower, and left ventricular function was
equally impaired, with and without abrupt ECG changes .
Saran et al. (4) used a cutoff point of 30% ST segment
resolution at 3 h, and Barbash et al . (18) used 50% resolution
at l h after the initiation of thrombolytic therapy . In both
studies a lesser de of ST segment elevation resolution
was associated with a significantly worse outcome . How-
ever, both studies had the limitation that the "good risk"
groups with more ST segment resolution included too many
patients with still severely depressed left ventricular func-
tion .
Applying two cutoff points of ST segment resolution can
solve these problems . Complete ST segment resolution
allows identification of a large subset of patients with excel-
lent survival . However, they carry a slightly higher proba-
bility of nonfatal reinfarction . An appropriate predischarge
stress test may identify those patients who could additionally
benefit from early angiography and revascularization maneu-
vers. Patients with anterior infarction and only partial ST
segment resolution despite reperfusion have an increasing
mortality risk over the long term (Fig . I) and may benefit
most from more vigorous adjunctive pharmacotherapy .
Lack of ST segment resolution identifies patients who have
a poor prognosis without reperfusion and in whom reperfu-
sioa might be expected to provide substantial benefit . These
patients may be candidates for immediate coronary angiog-
raphy and rescue percutaneous transluminal coronary angio-
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plasty (19) or rescue high dose intracoronary thrombolysis to
establish vessel patency (20).
However, whether and which patients will benefit from
early intervention is still a matter of debate (11,21) . Benefit
may be expected, especially in patients with a particularly
high mortality risk, such as those with recurrent infarction
(22) . However, in diabetic patients without previous infarc-
tion a conservative strategy might be preferable . In these
patients invasive procedures had been shown to be associ-
ated with increased mortality (22) . In this respect it is
noteworthy that patients with diabetes in this study comprise
the only risk group in which mortality remained high regard-
less of complete ST segment resolution (Table 5) .
Study limitations. Although we had first performed a
prospective, small study that established the predictive
value of the three ST segment resolution groups with similar
results (5), the current study is a retrospective analysis .
Adding 127 patients (8%) with only slight ST segment
elevation to the group with complete ST segment resolution
is data derived. However, this was done only because it is
clinically reasonable and meaningful. Complete ST segment
resolution was measured in 50 patients, partial resolution in
42 and no resolution in 35 patients . Reevaluation of all data
with these patients in their respective groups changed virtu-
ally no result . Moreover, to ensure that the special compo-
sition of the complete ST segment resolution group did not
violate the fundamental basic hypothesis of a good prognosis
in patients with complete ST segment resolution, the data
were reanalyzed after complete removal of the cohort of 127
patients with slight ST segment elevation. Again, the results
were almost unchanged. Compared with Table 6, the odds
ratio for 21-day mortality was 2 .8 and for 2-year mortality
1.7. The corresponding 95% confidence intervals were 1 .6 to
21-Day Mortality
ST segment resolution <30% 3 .4 2.9 1 .7-4 .9 0.0001
Age z65 yr 2 .8 2.2 1 .3-3 .8 0.005
Anterior infarction 2 .4 2 .0 IA-3 .5 0.01
Large sum of ST segment elevationt 1 .5
1 .s 1 .0-3 .0 0.04
2-Year Mortality
Age M65 yr 3 .0 2.5 1 .8-3 .6 0.
Previous infarction 2 .7 2 .4 1 .7-3,4
0 .0001
ST segment resolution <30 2 .3 1 .9 1 .3-2 .6 0 .
Abrupt heart failure 2 .5 1 .S 1 .2-2 .6 0 .003
Diabetes mellitus 2 .7 1,9 1 .2-2 .9 0 .(
Anterior infarction 1 .8 1 .6 1 .2_2 .3 0,005
Large sum of ST segment elevations 1 .3 1 .5 1 .1-2 .1 0 .02
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4.8 and 1 .2 to 2 .4, respectively . Infarct size and left ventric-
ular function in the group with complete ST segment reso-
lution remained nearly identical (compared with Table 2
[CIA-MB se!
-~-n activity curves 1 .3 ± 1 .1 Urni x h; new Q
waves 1 .8 ± 1 .4 ; ejection fraction 60 ± 101).
We did not intend to evaluate the prognostic use of
various risk factors per se in patients with evolving myocar-
dial infarction. Therefore, no statistical adjustment was
attempted for the 50 deaths occurring in patients who either
died before the 3-h ECG (most were in cardiogenic shock) or
had significant conduction disturbances . Rather, the aim of
the analysis was to estimate within the various clinical
variables the individual risk of a particular patient not
already otherwise identified to carry a high risk of d~ing
because of the presence of cardiogenic shock or bundle
branch block . In this regard differences in baseline charac-
teristics, such as slightly older age and a higher proportion of
diabetic patients in the no-ST segment resolution group, are
less relevant .
Conclusions. Retrospective analysis of a large, well char-
acterized patient group showed that the amount of ST
segment resolution 3 h after the start of streptokinase or
placebo infusion conveys useful information about the out-
come of patients with acute myocardial infarction regardless
of whether they were treated with thrombolysis . In the
preceding study (5), the predictive power of the ECG mark-
ers had been superior to that of the reperfusion state alone,
as assessed noninvasively by an early abrupt increase in
serum CK activity measured in 15-min intervals. ST segment
resolution ?M predicts not only reperfusion but also the
development of small infarcts . These patients have a low
short- and long-term mortality rate . The group with ST
segment resolution <30% includes not only patients with
persistent vessel occlusion but also those in whom lack of
reperfusion is associated with the development of large
infarcts and, accordingly, high short- and long-term mortal-
ity rates. In patients with an overall higher risk of dying,
mortality rate is strongly determined by the extent of early
ST segment resolution .
The predictive power of the simple, noninvasive early
marker of prognosis, easy to use in all patients who do not
have a bundle branch block and who survive 3 h after
hospital admission, seems extraordinarily strong . Just two
12-lead ECGs, one recorded at hospital admission, the other
3 h later, may be helpful for a timely triage of patients to
appropriate therapeutic interventions .
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